Zhejiang Huakang Pharmaceutical Co., Ltd. (SHA:605077)

China flag China · Delayed Price · Currency is CNY
10.27
+0.23 (2.29%)
Jul 27, 2026, 3:00 PM CST
Market Cap3.01B -44.2%
Revenue (ttm)4.56B +52.5%
Net Income141.43M -47.5%
EPS0.46 -36.0%
Shares Out 299.43M
PE Ratio21.84
Forward PEn/a
Dividend0.50 (4.98%)
Ex-Dividend DateJun 17, 2026
Volume3,921,499
Open10.05
Previous Close10.04
Day's Range9.99 - 10.32
52-Week Range9.97 - 20.20
Beta0.72
Analystsn/a
Price Targetn/a
Earnings DateAug 21, 2026

About SHA:605077

Zhejiang Huakang Pharmaceutical Co., Ltd. engages in the research, production, and sale of polyols and starch sugar worldwide. The company offers polyols products such as xylitol, is a polyol that occurs naturally regular sugar raise blood sugar levels; sorbitol, is produced by the catalytic hydrogenation of D-glucose and is available as a free-flowing crystalline powder, and as aqueous solutions; maltitol a bulk sweetener produced from naturally occurring compounds in corn; erythritol, is produced by the enzymatic hydrolysis of starch into glu... [Read more]

Industry Chemicals
Sector Materials
Founded 2001
Employees 2,248
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 605077
Full Company Profile

Financial Performance

In 2025, SHA:605077's revenue was 4.19 billion, an increase of 49.15% compared to the previous year's 2.81 billion. Earnings were 200.30 million, a decrease of -25.40%.

Financial Statements